Table 1.
Baseline Characteristics of HCC Patients Refractory to Conventional TACE
| Characteristics | Value |
|---|---|
| Sex | |
| Men | 18 |
| Woman | 1 |
| Median age, year | 69(43–80) |
| Etiology | |
| HBV infection | 19 |
| Other factor | 0 |
| BCLC staging classification | |
| A | 3 |
| B | 16 |
| C | 0 |
| Median AFP, ng/mL | 228.2(3.5–3526) |
| Mean size of tumour, cm | 4.3(1.5–11.9) |
| Total no. of tumour | 21 |
| Target tumour location | |
| Left lobe | |
| S2 | 1 |
| S3 | 3 |
| S4 | 4 |
| Right lobe | |
| S5 | 1 |
| S6 | 2 |
| S7 | 3 |
| S8 | 4 |
| S5–6 | 1 |
| S5–8 | 2 |
| No. of previous TACE, median | 4 |
Note: Data are presented as number or median (range).
Abbreviations: AFP, alpha-fetoprotein; BCLC staging classification, Barcelona Clinic Liver Cancer staging classification; HBV, hepatitis B virus; TACE, transarterial chemoembolization.